- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03348475
Binge Focused Therapy: A Guided, Self-help, Group-based Approach for Binge Eating Disorder
January 23, 2020 updated by: Aaron Keshen, Nova Scotia Health Authority
Binge Focused Therapy: Examining an Accessible, Cost-effective, Guided, Self-help, Group-based Approach for the Treatment of Binge Eating Disorder
The "Brain Over Binge Recovery Guide" (Hansen, 2016), is a self-help approach that incorporates fundamental aspects of Acceptance and Commitment Therapy, Dialectical Behavioural Therapy, Motivational Enhancement Therapy and addictions treatment.
This approach has been streamlined into a guided self-help protocol (Binge Focused Therapy, or BFT) that can be delivered by undergraduate students with minimal mental health experience in 3 group sessions spread over 8 weeks (i.e., Week 1, Week 2, Week 8).
The aim of this proof-of-concept study is to provide preliminary data to examine whether this approach is feasible and has clinical potential for patients with binge eating disorder.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H2E2
- Nova Scotia Health Authority
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 years or older;
- Meets DSM-5 criteria for moderate to severe Binge Eating Disorder (BED) as determined through screening interview by an eating disorder psychiatrist and validated with the Eating Disorder Diagnostic Scale (a self-report screening tool);
- Provides written informed consent.
Exclusion Criteria:
- Currently receiving treatment for BED;
- Is taking a psychotropic medication (e.g., antidepressant, stimulant, etc.) AND the dose has been changed 2 weeks prior to baseline;
- Insufficient knowledge of English.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
Binge Focused Therapy (BFT) Intervention
|
The intervention, Binge Focused Therapy, is a 3-session, 8-week, non-expert guided self-help program.
Participants will attend sessions at Week 1, Week 2, and Week 8 at the Nova Scotia Health Authority Eating Disorder Clinic.
Each session will be approximately 2 hours in length.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Binge Eating Frequency
Time Frame: Baseline, Week 8, 1-year follow-up
|
Self-reported binge eating frequency will be assessed with the Eating Disorder Examination Questionnaire 6.0 (EDE-Q).
Binge eating frequency is measured on item 15 of the EDE-Q.
|
Baseline, Week 8, 1-year follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Binge Eating Severity
Time Frame: Baseline, Week 2, Week 8, 1-year follow-up
|
Self-reported binge eating severity will be assessed with the Binge Eating Scale (BES).
The BES is a 16-item measure, each item has 3-4 coded responses.
The total score ranges from 0-46, where a higher score indicates greater binge eating severity.
|
Baseline, Week 2, Week 8, 1-year follow-up
|
Remission Rate
Time Frame: Week 8, 1-year follow up
|
Remission defined as 100% reduction in binge episodes in the last 28 days of treatment phase preceding week 8, or in the last 28-days of follow-up phase.
|
Week 8, 1-year follow up
|
Response Rate
Time Frame: Week 8, 1-year follow up
|
Responders defined as ≥ 50% reduction in the number of binge episodes from baseline to either of the last two preceding weeks of treatment or follow-up.
|
Week 8, 1-year follow up
|
Change in General Eating Disorder Symptomatology
Time Frame: Baseline, Week 8, 1-year follow-up
|
Self-reported general eating disorder symptomatology will be assessed using the global score generated from the EDE-Q.
The EDE-Q is a 28-item measure that assesses four areas of eating disorder psychopathology (eating concern, shape concern, weight concern, dietary restraint).
Each item uses a Likert scale ranging from 0 (lowest frequency/severity) to 6 (highest frequency/severity).
The global score ranges from 0-6 where higher scores indicate greater impairment.
The global score is obtained using the mean of the four subscales.
|
Baseline, Week 8, 1-year follow-up
|
Change in Locus of Control of Behaviour
Time Frame: Baseline, Week 2, Week 8, 1-year follow-up
|
Self-reported locus of control of behaviour will be assessed using the Locus of Control of Behaviour scale (LCB).
The LCB scale is a 17-item measure.
Participants respond to each item using a Likert scale ranging from 0 (strongly disagree) to 5 (strongly agree).
Total scores range from 0-85, with higher scores indicating a greater degree of externality.
|
Baseline, Week 2, Week 8, 1-year follow-up
|
Change in Coping Self-Efficacy
Time Frame: Baseline, Week 2, Week 8, 1-year follow-up
|
Self-reported coping self-efficacy will be assessed using the Coping Self-Efficacy Scale (CSES).
The CSES is a 26-item measure.
Each item with be rated using a Likert scale from 1 (cannot do at all) to 10 (certain can do).
An average score will be obtained.
Higher scores indicate greater coping self-efficacy.
|
Baseline, Week 2, Week 8, 1-year follow-up
|
Motivation/Confidence/Readiness for Behaviour Change
Time Frame: Baseline and Week 2
|
This will be measured using responses to three Likert-style questions that assess the perceived value of changing binge eating, confidence in ability to change binge eating, and readiness to change binge eating.
Each item will be scored on a scale of 1 (not at all important/confident/ready) to 10 (extremely important/confident/ready).
Each item will be assessed independently.
Higher scores indicate greater motivation, confidence, and readiness.
|
Baseline and Week 2
|
Depression, Anxiety and Tension/Stress
Time Frame: Baseline
|
Self-reported depression, anxiety, and tension/stress will be assessed using the Depression Anxiety Stress Scale (DASS).
Participants will respond to 21-items each scored on a Likert scale from 0 (did not apply) to 3 (applied very much or most of the time).
A total score ranges from 0-126 with a higher score indicating greater impairment.
|
Baseline
|
Participant Satisfaction with Intervention
Time Frame: Week 8
|
Participants will respond to 3 Likert-style questions on a scale of 1 (very poor) to 6 (excellent) and several open-ended questions asking about their perceptions of the program.
Higher scores indicate greater satisfaction.
|
Week 8
|
Week 3 - 7 Adherence
Time Frame: Week 8
|
Participants' adherence to tracking binge frequency and use of defusion skills (i.e., Homework) between Sessions 2 and 3.
|
Week 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2018
Primary Completion (Actual)
October 3, 2019
Study Completion (Actual)
October 3, 2019
Study Registration Dates
First Submitted
November 16, 2017
First Submitted That Met QC Criteria
November 17, 2017
First Posted (Actual)
November 21, 2017
Study Record Updates
Last Update Posted (Actual)
January 27, 2020
Last Update Submitted That Met QC Criteria
January 23, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BFT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Binge-Eating Disorder
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
ShireCompleted
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedBinge-Eating Disorder | Eating Disorders | Eating Behavior | Eating Disorder | Binge Eating Disorder Associated With ObesityBrazil
-
BioprojetRecruiting
-
Lindner Center of HOPEJazz PharmaceuticalsRecruiting
-
Idorsia Pharmaceuticals Ltd.Completed
-
University of ChicagoTakedaCompleted
-
Drexel UniversityCompleted
Clinical Trials on Binge Focused Therapy (BFT) Intervention
-
Nova Scotia Health AuthorityCompletedBinge Eating DisorderCanada
-
University of RwandaCompletedPatient EngagementRwanda
-
Universidad Rey Juan CarlosMinisterio de Economía y Competitividad, SpainTerminatedStress, Physiological | Depressive Symptoms | Anxious Symptoms | GuiltSpain
-
University of California, Los AngelesActive, not recruitingChildren With AutismUnited States
-
The Miriam HospitalUniversity of RochesterCompletedSexual BehaviorUnited States
-
Gia MuddNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk Reduction BehaviorUnited States
-
University of DelawareUniversity of Pittsburgh; Duke University; National Institute on Aging (NIA)CompletedOsteoarthritis | Chronic Low-back Pain | Hip Impairments | Hip-spine SyndromeUnited States
-
Florida State UniversityMary Oglesby ShapiroCompletedAnxiety | Intolerance of UncertaintyUnited States
-
University of South CarolinaMedical University of South Carolina; National Institute on Deafness and Other...RecruitingStroke | Aphasia | Stroke RehabilitationUnited States
-
University of Sao Paulo General HospitalRecruitingTemporomandibular Joint Disorders | Extracorporeal Shockwave TherapyBrazil